Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H13NO3 |
| Molecular Weight | 207.2258 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)NC(CC1=CC=CC=C1)C(O)=O
InChI
InChIKey=CBQJSKKFNMDLON-UHFFFAOYSA-N
InChI=1S/C11H13NO3/c1-8(13)12-10(11(14)15)7-9-5-3-2-4-6-9/h2-6,10H,7H2,1H3,(H,12,13)(H,14,15)
| Molecular Formula | C11H13NO3 |
| Molecular Weight | 207.2258 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: http://adisinsight.springer.com/drugs/800003808Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/7340854
Sources: http://adisinsight.springer.com/drugs/800003808
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/7340854
AFALANINE was developed by Medea Research in Italy and licensed to Pulitzer. Phase III clinical trials of MR 708 were completed by Pulitzer. Antidepressant; Antiparkinsonian; Neuroprotectant; Nootropic, Dopamine receptor agonist, was used to treat Major depressive disorder.
CNS Activity
Originator
Sources: http://adisinsight.springer.com/drugs/800003808
Curator's Comment: AFALANINE was developed by Medea Research in Italy and licensed to Pulitzer.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2096905 Sources: http://adisinsight.springer.com/drugs/800003808 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Digestive proteolytic activity in the Sunn pest, Eurygaster integriceps. | 2009 |
|
| Genetic algorithms as a tool for capillary electrophoresis method development. | 2002 |
|
| [Isolation and characteristics of immobilized aminoacylase from Streptoverticillium olivoreticuli]. | 2001-03-10 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.google.com/patents/CA1144162A?cl=en
Dogs/rats - AFALANINE (MR-708) produced a mild and transienth hypertension when given to narcotized dogs at the dosage rate of 4.5 mg/kg, and to rats narcotized by bilateral vagotomy at the dosage rate of 5 mg/kg
Route of Administration:
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:17:14 GMT 2025
by
admin
on
Mon Mar 31 18:17:14 GMT 2025
|
| Record UNII |
FFW2NGO18S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
||
|
NCI_THESAURUS |
C73539
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
21626
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
PRIMARY | |||
|
SUB05280MIG
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
PRIMARY | |||
|
2000
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
PRIMARY | |||
|
C72682
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
PRIMARY | |||
|
43242
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
PRIMARY | |||
|
2901-75-9
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
PRIMARY | |||
|
100000087706
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
PRIMARY | |||
|
FFW2NGO18S
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
PRIMARY | |||
|
DTXSID3045697
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
PRIMARY | |||
|
CHEMBL134570
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
PRIMARY | |||
|
220-793-9
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
PRIMARY | |||
|
6575
Created by
admin on Mon Mar 31 18:17:14 GMT 2025 , Edited by admin on Mon Mar 31 18:17:14 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |